Caloporoside derivatives, methods of their preparation and use

US6596694B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Claudia Eder · Hofheim, DE
• Michael Kurz · Neustadt, DE
• Mark Brönstrup · Frankfurt, DE
• Luigi Toti · Hochheim, DE

Key dates

• Filing date: Mar 8, 2002
• Grant date: Jul 22, 2003
• Expiry date: Mar 8, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to novel caloporoside derivatives and method of their use. The caloporoside derivatives may be formed by fermentation of microorganisms, such as Gloeoporus dichrous (Fr.: Fr.) Bres. ST001714 (DSM 13784). The invention also relates to use to a process for preparing caloporoside derivatives, drugs comprising such compounds, and methods of their use. The invention further relates to the microorganism Gloeoporus dichrous Bres. ST001714 (DSM 13784).